metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis (English Edition)
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis (English Edition) Eating frequency has an inverse correlation with adiposity measures and non-inva...
Información de la revista
Vol. 35. Núm. 1.
Páginas 21-31 (enero - febrero 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
171
Vol. 35. Núm. 1.
Páginas 21-31 (enero - febrero 2023)
Original article
Acceso a texto completo
Eating frequency has an inverse correlation with adiposity measures and non-invasive arterial stiffness parameters in healthy adult people
La frecuencia de alimentación tiene una correlación inversa con las medidas de adiposidad y los parámetros de rigidez arterial no invasivos en personas adultas sanas
Visitas
171
Sajjad Arefiniaa, Lida Jarahib, Hamed Khedmatgozara,c, Saeed Eslami Hasan Abadid, Mohammad Reza Shadmand Foumani Moghadame, André Tchernoff, Hosein Soleimaniniaa, Reza Rezvania,
Autor para correspondencia
RezvaniR@mums.ac.ir

Corresponding author.
a Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
b Department of Community Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
c Center for Biotechnology and Genomics, Texas Tech University, Lubbock, TX, USA
d Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
e Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran
f Centre de Recherche Institut Universitaire de Cardiologie & Pneumologie de Québec, Université Laval, Québec, Canada
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (6)
Table 1. Basic characteristics of the study participants: the PERSIAN cohort study (n=658).
Table 2. Biochemistry tests, non-invasive arterial stiffness parameters, and central blood pressure in participants according to their EF: the PERSIAN cohort study (n=658).
Table 3. EF and the non-invasive arterial stiffness parameters by total energy intake level: the PERSIAN cohort study (n=658).
Table 4. Comparison of the association of lifestyle with non-invasive arterial stiffness parameters, after adjustment for age, heart rate, BMI and cardiovascular risk factors.
Table 5. Anthropometric indices in men participants according to their EF: the PERSIAN Cohort Study (n=658).
Table 6. Anthropometric indices in women participants according to their EF: the PERSIAN cohort study (n=658).
Mostrar másMostrar menos
Abstract
Background

Lifestyle modifications have been recommended as an essential treatment approach for cardiovascular diseases. Recent studies have shown that eating frequency (EF) correlates with hypertension and related risk of organ damage. This study aimed to examine critical clinical implications to evaluate the association of EF with arterial stiffness parameters as an early marker of atherosclerosis manifestations.

Methods

A cross-sectional descriptive study was performed on 658 participants of the PERSIAN Organizational Cohort study in Mashhad, aged 30–70 years. Arterial stiffness was assessed by measurement markers of arteriosclerosis, including arterial age, augmentation index (AIx), augmentation pressure (AP), carotid-femoral pulse wave velocity (Cf-PWV), and central blood pressure. Differences in anthropometric indices, blood indices, and arterial stiffness parameters were evaluated across EF groups.

Results

Our data demonstrate that EF was positively correlated with total daily energy intake, and favourable profiles of adiposity and blood lipids. Subjects with an increased EF, had significantly lower AIx, AP, Arterial Age and Central blood pressure (P for trend<0.001) as compared to Lowest EF and not significant with PWV (P for trend, 0.19). Arterial stiffness was also significantly lower in those with increased EF compared with subjects with low EF. By Linear regression analysis, after adjustment for Confounding factors, except PWV, EF showed the associations with all of the non-invasive arterial stiffness parameters.

Conclusion

Increased EF is associated with a lower wave reflection and blood pressure in the central arteries.

Keywords:
Cardiovascular disease
Arterial stiffness
Eating frequency
Anthropometric indices
Hypertension
Resumen
Introducción

Las modificaciones del estilo de vida se han recomendado como un enfoque de tratamiento esencial para las enfermedades cardiovasculares. Estudios recientes han demostrado que la frecuencia de las comidas (EF) se correlaciona con la hipertensión y el riesgo relacionado de daño orgánico. Este estudio tenía como objetivo examinar las implicaciones clínicas críticas para evaluar la asociación de la EF con los parámetros de rigidez arterial como un marcador temprano de las manifestaciones de la aterosclerosis.

Métodos

Se realizó un estudio descriptivo transversal en 658 participantes del estudio de cohorte organizativo PERSIAN en Mashhad, de entre 30 y 70 años de edad. La rigidez arterial se evaluó mediante la medición de marcadores de arteriosclerosis, incluyendo la edad arterial, el índice de aumento (AIx), la presión de aumento (AP), la velocidad de la onda del pulso carótido-femoral (Cf-PWV) y la presión arterial central. Se evaluaron las diferencias en los índices antropométricos, los índices sanguíneos y los parámetros de rigidez arterial en los grupos de EF.

Resultados

Nuestros datos demuestran que la EF se correlacionó positivamente con la ingesta energética diaria total, los perfiles favorables de adiposidad y los lípidos sanguíneos. Los sujetos con una EF aumentada, tenían un AIx, una AP, una edad arterial y una presión arterial central significativamente menores (p de tendencia <0,001) en comparación con la EF más baja y no significativa con la PWV (p de tendencia, 0,19). La rigidez arterial también fue significativamente menor en los sujetos con una mayor FE en comparación con los sujetos con una FE baja. Mediante un análisis de regresión lineal, después de ajustar los factores de confusión, excepto la VOP, la frecuencia de las comidas se asoció con todos los parámetros de rigidez arterial no invasivos.

Conclusiones

El aumento de la FE se asocia a una menor reflexión de la onda y a una menor presión arterial en las arterias centrales en individuos aparentemente sanos.

Palabras clave:
Enfermedad cardiovascular
Rigidez arterial
Frecuencia de alimentación
Índices antropométricos
Hipertensión
Texto completo
Introduction

Hypertension, a major public health issue that because of its high prevalence, is an important preventable risk factor for cardiovascular disease (CVD) and chronic renal disease (CRD).1,2 Vascular stiffness is correlated, increasing the risk of chronic vascular diseases such as hypertension, stroke, and chronic kidney disease (CKD).3 Moreover, It could be a valid and independent objective for later cardiovascular events.4,5 Carotid-femoral pulse wave velocity (cfPWV), as a non-invasive measurement, is a gold-standard technique for assessing arterial stiffness. The ESC/ESH guidelines advocate using cfPWV for the measurement of large artery stiffness.6 It would be notable to mention that evaluation of total cardiovascular risk helps us to manage the best way to prevent CVD, while some classical risk factors might not be able to do.

Recent evidence shows that eating frequency (EF) inversely correlates with blood pressure and new-onset hypertension as well as subclinical atherosclerosis indices, especially in the carotids.7,8 However, additional investigations are necessary to authenticate these results.

On the other hand, Fabry and colleagues in 1964 observed an inverse association between regular EF and the prevalence of overweight in adults.9 Examinations show an association between higher with a lower BP and healthier bodyweight that may be useful for weight management.10–12 Nevertheless, studies, where EF and body weight were examined, have come to different conclusions, and others have shown no association between EF and markers of adiposity.13,14 Besides, studies have suggested that higher EF is usually associated with a more favourable lipid profile,15,16 lower insulin resistance,16,17 reduced risk of metabolic syndrome18 and a decrease in cardio-metabolic risk factors, like fasting glucose, triglycerides, total cholesterol, LDL-cholesterol, which may be mediated by the concomitant absence of abdominal obesity. Given that these metabolic factors are associated with vascular stiffness, arterial wave reflections, and blood pressure (BP),19,20 increased EF may affect the rate of progress of blood pressure and new-onset hypertension.

Thus, we aimed to evaluate the effect of EF on anthropometric indices and non-invasive arterial stiffness parameters in a sample of healthy adults.

Participants and methodsStudy population

We selected 658 healthy Iranian adult participants (321 men and 337 women) based on convenience sampling and sample saturation from the PERSIAN Organizational Cohort study at Mashhad University of Medical Sciences. This population-based prospective organization cohort study was conducted among 10,000 randomly selected participants aged 30–70 years in Mashhad, Iran (2017–2020) as part of the “Persian cohort” research project. Detailed information about the PERSIAN Cohort can be found elsewhere.21 People who do not have any non-communicable chronic diseases (self-declaration) are defined as healthy people. According to the Ethical Principles and Declaration of Helsinki, Informed consent was obtained individually from all participants. The ethics committee of the Mashhad University of Medical Sciences approved the study protocol (Code of Ethics: IR.MUMS.MEDICAL.REC.1397.322).

Assessment of baseline covariates

Self-declaration questionnaires collected data on sex, age, smoking habits, alcohol drinking, and physical activity using a valid and reliable questionnaire designed to collect data for all PERSIAN cohort sites. The physical activity dimension of participants’ lifestyles was assessed by using a validated physical activity questionnaire in the Persian cohort study. This questionnaire consists of 28 items and reports physical activity levels in MET-hours/day. MET values of each activity were extracted to identify activities using the compendium of physical activities. The mean rates of the participants’ metabolic equivalents (38.6METs/hour/day), who had less than 38.6METs/hour/day were defined as individuals with Poor-Physical Activity levels.

Smoking status is evaluated according to the National Health Interview Survey (NHIS). Current smokers were defined as persons who had smoked greater than 100 cigarettes and are currently smokers. Hookah use and alcohol consumption were also investigated in this study.

Assessment of dietary intake and eating frequency

At baseline, the amount of consumed energy and Eating frequency (EF) during the day were measured from a 24-h dietary recall. We assisted participants in estimating specific quantities of foods and beverages consumed. The instructions were explained to participants on how to report the number of foods and beverages consumed using standard household measurements. Then they were asked to record in detail the type and amount of foods and beverages consumed in the past 24h. An eating episode defines as every eating, drinking, or anything with energy content.

Because there is no consensus about the time interval that identifies one eating occasion, we retained the same cutoff time used in the previous study by Karatzi et al.7 If two Eating frequencies occurred in a 15-min interval or less, they were counted as one episode. Participants were divided into four groups according to the Eating frequency in their 24-h dietary recall as follows: 3≥, 4–5, and ≥6 meals per 24h. Energy intake is defined as the total caloric or energy content of food and beverage consumed that was assessed using modified NUTRITIONIST IV software.

Assessment of under- and over-reporting of energy intake

For the evaluation of under-reporting, the ratio of the energy intake (EI) to resting metabolic rate (RMR) was determined for each individual. RMR was measured by indirect calorimetry (MetaLyzer 3B, Cortex, Leipzig, Germany). We calculated the EI/RMR ratio and the corresponding cutoff to evaluate the validity of reported energy intakes. To check the relative degree of under- and over-reporting, we used the values defined by Goldberg et al.,22 and also the suggestion of Black et al. On the cutoff ratio of EI/RMR to over-reporting.23 Therefore, in the present study, a range of 1.35–2.39 was considered an acceptable report of energy intake.

Anthropometric analysis

All anthropometric and dietary intake assessments were performed by trained nutritionists. Anthropometric measurements, including body weight, height, and WC, were obtained. A Body Shape Index was calculated based on waist circumference (WC) adjusted for height and weight and using the following equation described by Krakauer et al.24

and Body Round Index, which is calculated using the equation described by Thomas et al.25

Body composition was assessed by bioimpedance analysis (InBody770, Biospance Co., Ltd. Seoul, Korea) following the standard tetrapolar whole-body (hand to foot, HF) technique.

Assessment of cf-PWV

The evaluation of non-invasive arterial stiffness parameters was conducted by trained physicians using the SphygmoCor (SphygmoCor Cardiovascular Management System software version 1.3; AtCor Medical Pty. Ltd., Sydney Australia) that relied on application tonometry for the acquisition of the radial, carotid, and femoral blood pressure waveforms. Briefly, after at least 6h of overnight fast, measurements were performed in the morning in a supine position after at least five minutes of resting in a quiet and room-controlled temperature of 23–25°C.

According to the instructions of the device SphygmoCor XCEL PWA, we used a standard brachial cuff (which was analyzed by SphygmoCor software) to measure brachial pressures and capture a brachial waveform, also measured central blood pressure. For the cfPWV, a cuff was placed around the patient's femoral artery to evaluate the femoral waveform, and a tonometer was applied to measure the carotid waveform. We measured the participant's Carotid to Sternal Notch length (in millimetres) and also the length of Sternal Notch to Cuff (in millimetres). Moreover, the velocity is automatically determined by dividing the distance by the pulse transit time. After 10s of simultaneous valid carotid tonometer signal. The SphygmoCor software derived the ascending aortic pressure wave, predominantly equivalent to the pressure wave measured by an invasive catheter. The number of valuable cardiovascular measurements were determined from the aortic pressure wave, including central aortic systolic pressure, aortic augmentation pressure, and aortic augmentation index (AIx). The SphygmoCor Reference Age (Arterial age) for any given participant, is the age of healthy people in the reference population who have similar average aortic pressure parameters. The cfPWV was calculated using the distance and mean time difference between the two-recorded points.

Laboratory measurements

Blood sampling was drawn in the morning after 10–12h of fasting and collected into vacuum tubes (EDTA and Clot). Biochemical tests were analyzed by using the BT1500 analyzer (BT 1500; Biotecnica Instruments, Rome, Italy). The external quality control process is performed monthly by repeating experiments on two random samples in Mashhad Reference Laboratory (Dr. Ejtehadi Laboratory).

Exclusion criteria

To examine a sample of healthy individuals based on the entire Persian cohort population, we did not include individuals with the following characteristics: diabetes, deep vein thrombosis (DVT), and self-reported previous cardiovascular disease, presence of prosthetic material (stent-grafts) in the vasculature. Other Exclusion criteria were: pregnancy, lactation, clinical conditions that could hamper haemodynamic measurements (absence of femoral arterial pulse, SBP<90mmHg) and other factors that may have influenced arterial stiffness, e.g. extreme beliefs or behaviour related to diet, regular use of vitamins or mineral supplementation and past medical history of serious diseases.

Statistical analysis

A comparison of quantitative categorical variable changes across multivariate qualitative subgroups (EF groups) was assessed using analysis of variance (ANOVA) or nonparametric equivalent tests and performed using Trend analysis and P for trend report. Association of arterial stiffness parameters with behavioural habits, including EF, EI, smoking habits, alcohol use, physical activity, and sleep duration were assessed using different linear regression models by modifying the effect of confounding variables with a significance level of 0.05 and presented as beta and CI 95%. The same was done for the association of EF with anthropometric indices. Analysis of arterial stiffness parameters correlation with behavioural habits was adjusted for age, sex, systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, BMI, fasting blood sugar (FBS), and cholesterol (CHOL). Analysis of EF correlation with anthropometric indices as well was adjusted for age, sex, smoking habits, alcohol use, and physical activity. Nutritionist IV was used to analyze dietary energy intakes, and we used SPSS version 25 for statistical analysis.

Results

Overall, data from 658 healthy adults were analyzed. Descriptive baseline characteristics of participants according to sex are shown in Table 1. In this study, 321 men with a mean age of 40 (37–48) years and 337 women with a mean age of 39 (44–37) years (P-value=0.26) were included in the study. Arterial stiffness, central and peripheral blood pressure by sex were significantly different. Given that the distribution of fat differs between men and women, as expected, anthropometric measurements were also significantly different between the two genders.

Table 1.

Basic characteristics of the study participants: the PERSIAN cohort study (n=658).

  Women (n=337)  Men (n=321)  P-value 
Age (years)  39 (37–44)  40 (37–48)  0.26 
Height (cm)  159.29±5.50  172.84±10.60  <0.001 
Weight (kg)  64.19±7.86  77.3±9.97  <0.001 
BMI (kg/m225.21±2.54  25.5±2.45  0.114 
WC (cm)  87.06±7.30  92.4±8.57  <0.001 
Hip (cm)  96.15±4.34  99.7±4.42  <0.001 
WHtR  0.55±0.04  0.53±0.05  <0.001 
WHR  0.90±0.05  0.93±0.06  <0.001 
ABSI  0.08±0.00  0.08±0.00  0.022 
BRI  4.28±0.84  4±0.92  <0.001 
Body fat mass (kg)  24.08±5.25  20.2±6.03  <0.001 
Visceral fat area (cm2120.74±32.58  88.8±31.41  <0.001 
Skeletal muscle mass (kg)  21.5 (20.1–23.3)  31.9 (29.6–34.5)  <0.001 
Percent body fat (%)  37.1 (34.15–40.65)  26.1 (22.1–29.25)  <0.001 
Fat Free mass (kg)  39.8 (37.25–42.8)  56.7 (52.9–61.15)  <0.001 
Sleep Duration (h/24h)  7.3 (6.50–8)  7 (6.33–8)  0.001 
PA (MET-hour/day)  38.2 (36.18–40.68)  37.8 (35.36–40.73)  0.152 
FBS (mg/dl)  86 (81–94)  90 (82–98)  <0.001 
TG (mg/dl)  77 (58–114)  110 (159–77)  <0.001 
CHOl (mg/dl)  175 (151–197)  183 (161.50–207)  0.002 
HDL (mg/dl)  62 (53–71)  52 (47–61)  <0.001 
Urea (mg/dl)  25 (22–29)  31 (26.50–35)  <0.001 
Creatinine (mg/dl)  0.9 (0.8–11.01)  1.013 (1–1.26)  <0.001 
ALP (U/L)  146 (125–177)  170 (141–204.5)  <0.001 
GGT (U/L)  16 (13–21)  26 (20–34)  <0.001 
SGOT (U/L)  19 (16–22)  23 (19–26)  <0.001 
SGPT (U/L)  18 (14–23)  26 (20–34)  <0.001 
Energy intake (kcal)  1776 (1643.5–1909.5)  2049 (1890.5–2257.5)  <0.001 
Alcohol consumption (%)  3 (0.9%)  18 (5.6%)  0.001 
Smoking (%)  5 (1.5%)  45 (13.9%)  <0.001 
CF-PWV (m/s)  6.93±1.29  7.4±1.28  <0.001 
AIx (%)  28.73±10.24  24.1±10.41  <0.001 
AP (mmHg)  9.11 (6.74–12.37)  7.5 (5.36–10.87)  <0.001 
Arterial age (year)  40 (31–56)  48 (37–62)  <0.001 
C-SBP (mmHg)  105.16 (98.02–112.87)  107.34 (101.31–114.35)  <0.001 
C-DBP (mmHg)  72 (77.89–66.96)  74.11 (69.74–79.79)  <0.001 
SBP (mmHg)  96 (90–104)  106 (98–114)  <0.001 
DBP (mmHg)  62 (60–70)  70 (62–76)  <0.001 

BMI, body mass index; WC, waist circumference; WHtR, waist-to-height ratio; WHR, waist-to-hip ratio; ABSI, A Body Shape Index; BRI, Body Roundness Index; PA, Physical Activity Scores; TG, Triglycerides; FBS, Fasting Blood Glucose; CHO, Total Cholesterol; ALP, Alkaline Phosphatase; GGT, Gamma-Glutamyl Transpeptidase; SGPT, Aspartate transaminase(AST); SGPT, Alanine transaminase(ALT); CF- PWV, carotid femoral pulse wave velocity; AIx, Augmentation index; AP, Augmentation pressure; C-SBP, Central Systolic Blood Pressure; C-DBP, Central Diastolic Blood Pressure; SBP, Brachial Systolic Blood Pressure; DBP, Brachial Diastolic Blood Pressure.

Table 2 shows that there was a significant difference in the comparison of variables of arterial stiffness and central blood pressure in different groups of EF. The incremental trend was significant for all variables (P for trend<0.001) except PWV. For biochemistry tests, lipid profile, and liver enzymes were inversely correlated with the number of meals: those who consumed a larger number of meals had better blood lipid profiles. Liver enzymes (alkaline phosphatase and gamma glutamine transferase) were also significantly lower in subjects with higher EF. The incremental trend was also significant for all variables except blood cholesterol and urea nitrogen.

Table 2.

Biochemistry tests, non-invasive arterial stiffness parameters, and central blood pressure in participants according to their EF: the PERSIAN cohort study (n=658).

    TotalP for trend 
  3EF  EF=EF=EF 
FBS  90.52±14.78  88.56±10.81  90.19±13.31  88±12.36  0.20 
TG  100.50 (69–156.25)  101 (71–139)  98 (67–136.5)  75.50 (61–119)  <0.001 
CHOL  182.15±37.23  184.39±34.35  183.67±37.52  174.78±37.94  0.09 
HDLc  56.77±12.02  59.39±13.87  59.10±14.03  59.75±15.11  0.06 
BUN  27.81±6.48  29.59±6.27  27.74±7.01  27.32±6.79  0.20 
Creatinine  1.02±0.2  1.07±0.2  1.01±0.2  0.98±0.2  0.05 
SGOT  22.23±6.02  22.29±6.54  20.78±5.97  21.10±5.74  0.03 
SGPT  25.04±11.10  24.28±10.49  22.56±9.27  22.68±10.32  0.02 
ALP  173.40±40.84  165.59±42.14  161.35±48.71  158.39±43.8  0.003 
GGT  22 (15–31)  21 (16–31)  21 (15–29.25)  18 (14–24)  <0.001 
Dif arterial age  +22 (+17,+30)  +10 (+4,+15)  0 (−16,+5)  −9 (−16,−2)  <0.001 
Central SBP  112.91±10.37  107.86±10.33  107.73±11.93  104.06±9.22  <0.001 
Central DBP  76.86±8.55  73.84±8.03  74.27±8.91  72.39±7.28  <0.001 
C_Meanp  92.03±9.46  87.30±8.92  87.56±10.26  85.09±8.04  <0.001 
C_Ap  10.98 (8.42–13.95)  9.05 (6.67–11.94)  7.78 (5.87–12.08)  7.17 (4.96–9.95)  <0.001 
AIx  31.24±9.52  28.04±11.52  25.47±10  23.22±9.44  <0.001 
PWV  7.29±1.43  7.08±1.23  7.35±1.40  6.99±1.18  0.19 

EF, eating frequency; TG, triglycerides; FBS, fasting blood glucose; CHO, total cholesterol; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; SGPT, aspartate transaminase (AST); SGPT, alanine transaminase (ALT); Dif arterial age, differences between arterial and biological age; CF- PWV, carotid femoral pulse wave velocity; AIx, Augmentation index; AP, Augmentation pressure; C-SBP, central systolic blood pressure; C-DBP, central diastolic blood pressure.

Effect estimates with a p-value <0.05 are indicated in bold.

dif arterial age was calculated by subtracting the chronological age from arterial age (arterial agechronological age).

By stratifying the energy intake with arterial stiffness, we reported an inverse correlation between those who consumed 2500>TEI1600kcal or ≥2500kcal and arterial stiffness parameters (Table 3, P values<0.05) while participants who had lower total energy intake showed just a meaningful change in arterial age, which decreased significantly with an increasing number of meals.

Table 3.

EF and the non-invasive arterial stiffness parameters by total energy intake level: the PERSIAN cohort study (n=658).

  TotalP for trend 
  3 ≥ EF  EF=4  EF=5  EF ≥ 6     
<1600kcalPWV  7.24±1.25  6.91±1.15  7.22±0.98  6.67±0.95  0.25 
AIx  34.19±9.46  33.68±11.92  35.90±6.43  31.59±7.52  0.61 
AP  11.99 (9.51–15.89)  11.21 (8.75–15.14)  12.16 (9.91–16.43)  10.65 (8.58–13.63)  0.42 
Dif arterial age  +19 (+14,+30)  +9.5 (+3,+16.25)  +2 (−0.7,+9.75)  −7 (−13,−2)  <0.001 
2500>TEI1600kcalPWV  7.57±1.15  7.25±1.15  7.44±1.45  7.02±1.20  0.01 
AIx  29.66±9.14  25.39±10.17  26.48±9.60  23.92±8.40  <0.001 
AP  10.55 (7.91–13.45)  7.53 (6.32–10.65)  8.47 (6.54–12.33)  7.35 (5.16–9.8)  <0.001 
Dif arterial age  +22 (+18,+29)  +10 (+4,+15)  0 (−6,+5.25)  −9 (−15,−2)  <0.001 
≥2500kcalPWV  8.22±0.88  7.45±0.86  7.35±0.81  7.09±0.84  0.03 
AIx  21.25±7.6  19.88±7.9  19.54±8.79  15.68±11.07  0.01 
AP  7.25 (7.25–7.25)  3.26 (3.26–3.26)  5.61 (4.05–7.76)  4.08 (2.2–7.01)  0.10 
Dif arterial age  +11 (+6,+18)  +5 (+1,+8)  −1 (−5.7,+3.75)  −13 (−16,−5)  <0.001 

EF, eating frequency; Dif arterial age, differences between arterial and biological age; CF-PWV, carotid-femoral pulse wave velocity; AIx, augmentation index; AP, augmentation pressure;

Effect estimates with a p-value <0.05 are indicated in bold.

dif arterial age was calculated by subtracting the chronological age from arterial age(arterial agechronological age).

In the linear regression model (Table 4), energy intake was inversely correlated with AIx, AP and arterial age (improvement status by increasing energy). In contrast, when each sex was examined individually, PWV was positively correlated in females (Beta=0.25, sig=0.002, PWV increased by increasing energy). EF was inversely associated with all indices of arterial stiffness except PWV.

Table 4.

Comparison of the association of lifestyle with non-invasive arterial stiffness parameters, after adjustment for age, heart rate, BMI and cardiovascular risk factors.

Model  Unstandardized coefficients  Standardized coefficientsSig.  Partial correlations 
  B  Std. error  Beta     
PWV
aEnergy intake  –  –  –  0.96  −0.02 
aEF group  –  –  –  0.32  −0.04 
aSmoking  –  –  –  0.76  0.01 
aAlcohol consumption  –  –  –  0.72  0.01 
aPA  –  –  –  0.34  −0.04 
Arterial age
Energy intake  0.009  0.003  0.14  0.005  0.11 
EF group  8.58  0.57  0.59  <0.001  0.52 
Smoking  7.02  1.76  0.12  <0.001  0.16 
aAlcohol consumption  –  –  –  0.77  −0.01 
aPA  –  –  –  0.27  −0.04 
AIx
Energy intake  0.008  0.003  0.20  0.001  0.13 
EF group  2.01  0.46  0.20  <0.001  0.17 
Smoking  2.68  1.4  0.07  0.06  0.07 
aAlcohol consumption  –  –  –  0.43  −0.03 
aPA  –  –  –  0.46  −0.03 
AP
Energy intake  0.003  0.001  0.16  0.009  0.10 
EF group  1.01  0.20  0.27  <0.001  0.21 
Smoking  1.06  0.61  0.1  0.009  0.10 
aAlcohol consumption  –  –  –  0.32  −0.04 
aPA  –  –  –  0.46  −0.03 

Linear Regression: Model was adjusted for gender, age, SBP, DBP, heart rate, BMI, FBS, CHOL

EF Group, EF Group; PA, Physical Activity Scores; Dif arterial age, differences between arterial and biological age; CF-PWV, carotid femoral pulse wave velocity; AIx, Augmentation index; AP, Augmentation pressure.

a

Variable excluded from the model.

Effect estimates with a p-value <0.05 are indicated in bold.

dif arterial age was calculated by subtracting the chronological age from arterial age(arterial age- chronological age)

ANOVA tests comparing anthropometric indices and metabolic variables in different groups of EF showed that in both sexes (Tables 5 and 6) for most variables significantly increased with an increasing number of meals. It is observed that with an increasing number of meals, there is a significant decrease in abdominal obesity (WHtR, WHR, and WC), visceral fat surface, and body fat mass.

Table 5.

Anthropometric indices in men participants according to their EF: the PERSIAN Cohort Study (n=658).

  menP for trend 
  3EF  EF=EF=EF 
Weight (kg)  78.44±9.46  76.82±8.93  77.78±11.70  76.36±9.65  0.33 
WC (cm)  94.3±9.11  92.56±8.85  92.47±8.62  90.57±7.36  0.01 
Hip circumstance (cm)  100.37±4.78  99.45±4.37  99.69±4.27  99.52±4.41  0.34 
WHR  0.93±0.057  0.92±0.05  0.92±0.06  0.9±0.04  0.007 
WHtR  0.54±0.05  0.53±0.04  0.53±0.05  0.52±0.04  0.03 
ABSI  0.081±0.003  0.08±0.003  0.08±0.003  0.079±0.003  0.008 
BRI  4.07±0.82  4.04±1.03  4.07±0.97  3.83±0.75  0.18 
Skeletal muscle mass  32.08±3.85  31.9±3.63  32.28±4.35  32.32±4.29  0.62 
Visceral fat area (cm295.69±35.11  89.1±33.67  89.97±31.71  81.48±22.26  0.01 
Fat free mass  57.01±6.33  56.69±6.03  57.41±7.33  57.38±7.13  0.62 
Body fat mass  21.42±6.73  20.12±6  20.36±6.39  18.98±4.79  0.03 
BMI (kg/m225.54±2.24  25.45±2.66  25.67±2.46  25.43±2.29  0.92 

Effect estimates with a p-value <0.05 are indicated in bold.

BMI, body mass index; WC, waist circumference; WHtR, waist-to-height ratio; WHR, waist-to-hip ratio; ABSI, A Body Shape Index; BRI, Body Roundness Index.

Table 6.

Anthropometric indices in women participants according to their EF: the PERSIAN cohort study (n=658).

  WomenP for trend 
  3EF  EF=EF=EF 
Weight (kg)  64.56±6.52  65.4±8.88  65.16±7.90  62.68±7.48  0.14 
WC (cm)  88.24±6.74  87.99±8  87.89±7.45  85.46±6.73  0.02 
Hip (cm)  96.45±3.49  96.81±4.91  96.53±4.54  95.37±4.07  0.11 
WHR  0.91±0.05  0.90±0.04  0.9±0.04  0.89±0.04  0.02 
WHtR  0.55±0.04  0.55±0.05  0.54±0.04  0.53±0.04  0.008 
ABSI  0.08±0.003  0.08±0.002  0.08±0.002  0.07±0.002  0.23 
BRI  4.52±0.85  4.29±0.74  4.32±0.92  4.12±0.81  0.008 
Skeletal muscle mass  21.57±2.55  21.91±2.61  22.11±2.33  21.37±2.38  0.74 
Visceral fat area (cm2126.54±28.37  125.14±36.96  121.71±31.59  114.99±31.45  0.02 
Fat free mass  39.87±4.27  40.46±4.36  40.79±3.90  39.56±4.02  0.77 
Body fat mass  24.74±4.11  24.94±6.10  24.36±5.24  23.08±4.98  0.04 
BMI (kg/m225.71±2.18  25.45±2.51  25.31±2.76  24.21±2.53  0.02 

Effect estimates with a p-value <0.05 are indicated in bold.

BMI, body mass index; WC, waist circumference; WHtR, waist-to-height ratio; WHR, waist-to-hip ratio; ABSI, A Body Shape Index; BRI, Body Roundness Index.

A comparison of the results of mean arterial stiffness parameters in the number of meal groups in both sexes (Fig. 1) has shown that all parameters except PWV have a decreasing slope as the number of meals increases.

Figure 1.

Comparison of mean values of arterial stiffness markers among EF groups (stratified by gender). Participants in each group (EF3, EF=4, EF=5 and EF6) were 110(16.71%), 186(28.27%), 163(24.78%) and 199(30.24%), respectively. P-value derived using Oneway ANOVA analyses or Kruskal–Wallis Test for comparison mean or median of variables in each group of EF.

(0.29MB).
Discussion

In our study, the mean AIx in subjects with EF3 per day was about 25% higher compared to those with EF6. Considering that every 10% increase in cAIx was associated with an increase of 1.48-fold in cardiovascular mortality risk,26 we can expect that an increase of 30% of AIx may be related to increasing a 3.8-fold in cardiovascular mortality. Besides, arterial age, on average, was also higher (for about 30 years) in subjects with EF3, compared to those with EF6.

EF reflects the distribution of daily food intake, energy intake, and regular intake of nutrients in one or more meals. We have shown a significant inverse relationship between increased EF with abdominal obesity indices (WC, WHtR, and WHR), BMI, and visceral fat area in both sexes. However, previous studies have reported mixed results. Several studies have demonstrated an inverse relationship between EF and obesity.27,28 As Wang et al. In a meta-analysis study in 2016, reported that adults with higher EF had 17% lower probabilities of getting overweight and obese.29 In another study, Kim et al. in an adult Korean population have revealed that when diet quality is high, EF is inversely associated with obesity indicators.30 Zhu et al. suggested that adults with a higher EF in the USA had a healthier diet with lower energy density and better diet quality, and EF was inversely associated with body weight status.31 In contrast, a cross-sectional study of British adults showed positive associations of EF with BMI and WC,32 and some clinical trials, despite limitations (small sample size and insufficient follow-up time) found no association between weight loss and EF.33,34

The mechanisms underlying this inverse relationship are not fully clarified. It has been suggested that increased daily eating frequency, by a decrease in fasting intervals, might lead to higher thermogenesis, the decline means blood glucose concentrations and insulin secretion, which altogether would make higher insulin sensitivity.17,35,36 Moreover, higher EF is associated with better diet quality and lower energy density.31,37 According to the Healthy Eating Index (HEI), high quality of diet requires 30% or less energy intake (EI) of fat, limiting calories from saturated fats to less than 10% and lower protein intake.38 High EF is associated with low EI from fat and protein but high EI from carbohydrates due to the increased consumption of healthy-ingredient snacks like fruits.39–41 On the other hand, available data show that the Small, frequent meals per day may lead to improved lipid profiles, less insulin resistance, reduced lipogenesis and a lower risk of metabolic syndrome.16–18

Similarly, as the number of meals increased, we also saw an improvement in the lipid profile. Besides, we observed an inverse association of liver cell integrity markers (AST and ALT) and cholestasis parameters (GGT and ALP) with EF. Thus, it may be of particular value to separate large amounts of food consumed in a meal into more Eating frequencies.

The innovative finding of the present study was that high EF was associated with a fall in BP, wave reflections in the overall population and by subgroup analysis at three different levels of the total energy consumed.

In the regression model, we also observed that EF and EI were inversely associated with Arterial age, cAIx and AP in both sexes. On the other hand, EI had a positive relationship with PWV in men. On the other hand, EI had a positive relationship with PWV in men. A recent study found that in apparently healthy adults, intima-media thickness (IMT) differed as a function of EF by a greater degree for those who had higher EI.7 In another study, the benefits of higher EF on cardiovascular mortality risk appeared to be greater in people who had reported higher EI (≥2500kcal) than among those who had reported lower EI.42

However, it is often difficult to determine if a high daily EF in itself has beneficial health effects, because dietary behaviours in the real world are much more complicated, and people should monitor the quantity and quality of each meal. Increasing the frequency of meals with high-energy foods results in more energy consumption, which can have a negative impact on health through increased calorie intake, energy imbalance, and, eventually obesity.42 Calorie intake is a significant health factor. Low energy and excessive energy consumption indicate various forms of malnutrition that lead to undesirable changes in body composition, body function, and premature mortality.43,44 The exact amount of calories needed for optimal health and performance varies by individual, depending on their genetic history, age, energy intake, and diet composition. Also, the amount of calories needed to slow down the ageing process is unclear.44

However, existing data support the notion that calorie restriction with adequate human nutrient intake causes many metabolic adaptions and reduces the risk of multiple chronic diseases.45 However, any amount of calorie restriction can be disadvantageous to specific populations, e.g. lean people, who have minimal body fat storage capacity. For example, it has been suggested that in people with lean body mass, there is no beneficial effect of calorie restriction on life expectancy can be expected. Nevertheless, for overweight or obese people, a decrease in excessive food intake can be partially beneficial.46

In this study, we did not observe a significant sex difference in arterial stiffness markers regarding EF. However, female participants had a higher difference between central and peripheral BP than males. Also, AP and, consequently, AIx were higher in women (Table 1 and Fig. 1). The higher AIx in women compared to men might be a possible explanation for the difference between central and peripheral BP. Age as a primary predictor of increasing AIx, but body height and heart rate also may have contributed.47,48 Nevertheless, overall, PWV was higher in men.

A major limitation of this study is the cross-sectional design, as we cannot draw conclusions in terms of causal relationships and cannot provide information about changes in cfPWV over time. Another disadvantage might be choosing a healthy population based on strict criteria for exclusion of those with risk factors, as it is expected that older adults were more affected by prohibitions. Also, because of inaccessibility and inadequate collaboration, only a 24-h dietary recall had been taken.

Our study has multiple strengths. First, an illustrated food model booklet and clear instructions, which assist in estimating specific quantities of consumed foods and beverages. Second, the level of dietary consciousness and desire for weight change may severely bias reported food intake in dietary reports. Therefore we used the Goldberg and Black et al. cutoff for the assessment of under- and over-reporting.22,23 Third, strict criteria to attain healthy participants as being strengths of our analyses and support the reliability of our reference values for cfPWV. Fourth, use the gold-standard method to evaluate arterial stiffness and estimate resting metabolic rate.

Conclusions

In conclusion, the main findings of this research include: 1-Increased EF was associated with a lower incidence of manifestations of arterial stiffness in central arteries in healthy subjects. 2-There was a significant inverse relationship between EF and the measures of abdominal adiposity in both genders. 3-Increased EF correlated with a better lipid profile and biochemical liver function tests. However, clinical research is required to confirm these results and public health recommendations should be cautious, as higher EF is associated with total energy intake, which could promote weight gain.

Funding

Iran Ministry of Health and Medical Education and Mashhad University of Medical Sciences.

Conflict of interest

The authors declare that they have no conflict of interest.

Acknowledgments

This study was supported by the Iran Ministry of Health and Medical Education and Mashhad University of Medical Sciences as part of the “Persian cohort” research project.

References
[1]
A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., et al.
The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report.
JAMA, 289 (2003), pp. 2560-2571
[2]
J. Stamler, R. Stamler, J.D. Neaton.
Blood pressure, systolic and diastolic, and cardiovascular risks: US population data.
Arch Intern Med, 153 (1993), pp. 598-615
[3]
G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. Böhm, et al.
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Blood Press, 22 (2013), pp. 193-278
[4]
C. Vlachopoulos, K. Aznaouridis, C. Stefanadis.
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.
J Am Coll Cardiol, 55 (2010), pp. 1318-1327
[5]
S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, et al.
Expert consensus document on arterial stiffness: methodological issues and clinical applications.
Eur Heart J, 27 (2006), pp. 2588-2605
[6]
B. Williams, G. Mancia, W. Spiering, E. Agabiti Rosei, M. Azizi, M. Burnier, et al.
2018 ESC/ESH Guidelines for the management of arterial hypertension.
Eur Heart J, 39 (2018), pp. 3021-3104
[7]
K. Karatzi, M. Yannakoulia, T. Psaltopoulou, P. Voidonikola, G. Kollias, T.N. Sergentanis, et al.
Meal patterns in healthy adults: Inverse association of eating frequency with subclinical atherosclerosis indexes.
Clin Nutr, 34 (2015), pp. 302-308
[8]
K. Karatzi, G. Georgiopoulos, M. Yannakoulia, E. Efthimiou, P. Voidonikola, A. Mitrakou, et al.
Eating frequency predicts new onset hypertension and the rate of progression of blood pressure, arterial stiffness, and wave reflections.
J Hypertens, 34 (2016), pp. 429-437
[9]
P. Fabry, J. Fodor, Z. Hejl, T. Braun, K. Zvolánková.
The frequency of meals, its relation to overweight, hypercholesterolaemia, and decreased glucose-tolerance.
[10]
H.M. Seagle, G.W. Strain, A. Makris, R.S. Reeves.
Position of the American Dietetic Association: weight management.
J Am Diet Assoc, 109 (2009), pp. 330-346
[11]
C. Berg, G. Lappas, A. Wolk, E. Strandhagen, K. Torén, A. Rosengren, et al.
Eating patterns and portion size associated with obesity in a Swedish population.
[12]
S. Kim, G. Park, J. Yang, S. Chun, H.-J. Yoon, M.S. Park.
Eating frequency is inversely associated with blood pressure and hypertension in Korean adults: analysis of the Third Korean National Health and Nutrition Examination Survey.
Eur J Clin Nutr, 68 (2014), pp. 481-489
[13]
H. Crawley, C. Summerbell.
Feeding frequency and BMI among teenagers aged 16–17 years.
Int J Obes, 21 (1997), pp. 159
[14]
C. Summerbell, R. Moody, J. Shanks, M. Stock, C. Geissler.
Relationship between feeding pattern and body mass index in 220 free-living people in four age groups.
Eur J Clin Nutr, 50 (1996), pp. 513-519
[15]
D.J. Jenkins, A. Khan, A.L. Jenkins, R. Illingworth, A.S. Pappu, T.M. Wolever, et al.
Effect of nibbling versus gorging on cardiovascular risk factors: serum uric acid and blood lipids.
Metabolism, 44 (1995), pp. 549-555
[16]
H.R. Farshchi, M.A. Taylor, I.A. Macdonald.
Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women.
Am J Clin Nutr, 81 (2005), pp. 16-24
[17]
D.J. Jenkins, T.M. Wolever, V. Vuksan, F. Brighenti, S.C. Cunnane, A.V. Rao, et al.
Nibbling versus gorging: metabolic advantages of increased meal frequency.
N Engl J Med, 321 (1989), pp. 929-934
[18]
J. Sierra-Johnson, A.L. Undén, M. Linestrand, M. Rosell, P. Sjogren, M. Kolak, et al.
Eating meals irregularly: a novel environmental risk factor for the metabolic syndrome.
Obesity, 16 (2008), pp. 1302-1307
[19]
Collaboration RVfAS. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors:‘establishing normal and reference values’. Eur Heart J. 2010;31:2338–50.
[20]
A. Benetos, C. Adamopoulos, J.-M. Bureau, M. Temmar, C. Labat, K. Bean, et al.
Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period.
Circulation, 105 (2002), pp. 1202-1207
[21]
H. Poustchi, S. Eghtesad, F. Kamangar, A. Etemadi, A.A. Keshtkar, A. Hekmatdoost, et al.
Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design.
Am J Epidemiol, 187 (2018), pp. 647-655
[22]
G. Goldberg, A. Black, S. Jebb, T. Cole, P. Murgatroyd, W. Coward, et al.
Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording.
Eur J Clin Nutr, 45 (1991), pp. 569-581
[23]
A. Black, W. Coward, T. Cole, A. Prentice.
Human energy expenditure in affluent societies: an analysis of 574 doubly-labelled water measurements.
Eur J Clin Nutr, 50 (1996), pp. 72-92
[24]
N.Y. Krakauer, J.C. Krakauer.
A new body shape index predicts mortality hazard independently of body mass index.
[25]
D.M. Thomas, C. Bredlau, A. Bosy-Westphal, M. Mueller, W. Shen, D. Gallagher, et al.
Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model.
Obesity, 21 (2013), pp. 2264-2271
[26]
G.M. London, J. Blacher, B. Pannier, A.P. Guérin, S.J. Marchais, M.E. Safar.
Arterial wave reflections and survival in end-stage renal failure.
Hypertension, 38 (2001), pp. 434-438
[27]
Y. Ma, E.R. Bertone, E.J. Stanek III, G.W. Reed, J.R. Hebert, N.L. Cohen, et al.
Association between eating patterns and obesity in a free-living US adult population.
Am J Epidemiol, 158 (2003), pp. 85-92
[28]
J. Ruidavets, V. Bongard, V. Bataille, P. Gourdy, J. Ferrieres.
Eating frequency and body fatness in middle-aged men.
Int J Obes, 26 (2002), pp. 1476-1483
[29]
Y.-Q. Wang, Y.-Q. Zhang, F. Zhang, Y.-W. Zhang, R. Li, G.-X. Chen.
Increased eating frequency is associated with lower obesity risk, but higher energy intake in adults: a meta-analysis.
Int J Environ Res Public Health, 13 (2016), pp. 603
[30]
S. Kim, J.H. Yang, G.-H. Park.
Eating frequency is inversely associated with BMI, waist circumference and the proportion of body fat in Korean adults when diet quality is high, but not when it is low: analysis of the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV).
Br J Nutr, 119 (2018), pp. 918-927
[31]
Y. Zhu, J.H. Hollis.
Associations between eating frequency and energy intake, energy density, diet quality and body weight status in adults from the USA.
Br J Nutr, 115 (2016), pp. 2138-2144
[32]
K. Murakami, M. Livingstone.
Eating frequency in relation to body mass index and waist circumference in British adults.
Int J Obes, 38 (2014), pp. 1200-1206
[33]
J.L. Bachman, H.A. Raynor.
Effects of manipulating eating frequency during a behavioral weight loss intervention: a pilot randomized controlled trial.
Obesity, 20 (2012), pp. 985-992
[34]
J.D. Cameron, M.-J. Cyr, E. Doucet.
Increased meal frequency does not promote greater weight loss in subjects who were prescribed an 8-week equi-energetic energy-restricted diet.
Br J Nutr, 103 (2010), pp. 1098-1101
[35]
D.J. Jenkins, A.L. Jenkins, T.M. Wolever, V. Vuksan, A.V. Rao, L.U. Thompson, et al.
Low glycemic index: lente carbohydrates and physiological effects of altered food frequency.
Am J Clin Nutr, 59 (1994), pp. 706S-709S
[36]
W. de Venne Verboeket-van, K. Westerterp.
Influence of the feeding frequency on nutrient utilization in man: consequences for energy metabolism.
Eur J Clin Nutr, 45 (1991), pp. 161-169
[37]
G.S. Aljuraiban, Q. Chan, L.M.O. Griep, I.J. Brown, M.L. Daviglus, J. Stamler, et al.
The impact of eating frequency and time of intake on nutrient quality and body mass index: the INTERMAP study, a population-based study.
J Acad Nutr Diet, 115 (2015), pp. 528-536
[38]
T.E. Kennedy, J. Ohls, S. Carlson, K. Fleming.
The healthy eating index: design and applications.
J Am Diet Assoc, 95 (1995), pp. 1103-1108
[39]
I. Holmbäck, U. Ericson, B. Gullberg, E. Wirfält.
A high eating frequency is associated with an overall healthy lifestyle in middle-aged men and women and reduced likelihood of general and central obesity in men.
Br J Nutr, 104 (2010), pp. 1065-1073
[40]
A. Marín-Guerrero, J. Gutiérrez-Fisac, P. Guallar-Castillón, J. Banegas, F. Rodríguez-Artalejo.
Eating behaviours and obesity in the adult population of Spain.
Br J Nutr, 100 (2008), pp. 1142-1148
[41]
D. Chapelot, C. Marmonier, R. Aubert, C. Allegre, N. Gausseres, M. Fantino, et al.
Consequence of omitting or adding a meal in man on body composition, food intake, and metabolism.
Obesity, 14 (2006), pp. 215-227
[42]
H.-J. Chen, Y. Wang, L.J. Cheskin.
Relationship between frequency of eating and cardiovascular disease mortality in US adults: the NHANES III follow-up study.
Ann Epidemiol, 26 (2016), pp. 527-533
[43]
J. Saunders, T. Smith.
Malnutrition: causes and consequences.
Clin Med, 10 (2010), pp. 624
[44]
L. Fontana, S. Klein.
Aging, adiposity, and calorie restriction.
JAMA, 297 (2007), pp. 986-994
[45]
T.J. LaRocca, C.R. Martens, D.R. Seals.
Nutrition and other lifestyle influences on arterial aging.
Age Res Rev, 39 (2017), pp. 106-119
[46]
E. Le Bourg.
Does calorie restriction in primates increase lifespan? Revisiting studies on macaques (Macaca mulatta) and mouse lemurs (Microcebus murinus).
Bioessays, 40 (2018), pp. 1800111
[47]
I.B. Wilkinson, H. MacCallum, L. Flint, J.R. Cockcroft, D.E. Newby, D.J. Webb.
The influence of heart rate on augmentation index and central arterial pressure in humans.
J Physiol, 525 (2000), pp. 263-270
[48]
B.P. McGrath, Y.L. Liang, D. Kotsopoulos, J.D. Cameron.
Impact of physical and physiological factors on arterial function.
Clin Exp Pharmacol Physiol, 28 (2001), pp. 1104-1107
Copyright © 2022. Sociedad Española de Arteriosclerosis
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.artere.2020.03.002
No mostrar más